A Compassionate Access Protocol For Those Patients Who Have Completed A4001029

ViiV Healthcare

Status

Conditions: HIV

Treatments: Drug: Maraviroc

Study type: Expanded Access

Funder types: Industry

Identifiers

NCT00801515

A4001090

Details and patient eligibility

About

This is a compassionate study to provide continued access to maraviroc for only those subjects completing study A4001029 who are showing clinical benefit. Assessments of safety and tolerability of maraviroc when added to OBT will be continued.

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients having completed study A4001029 in Canada and still deriving clinical benefit.

Exclusion criteria

• None